Българско ринологично сдружение. Съвременни концепции за лечението на хроничния риносинуит, 2012.
Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007; 45: 97–101.
Joe S. A systemic review of the use of intranasal steroids in the treatment of chronic rhinosinuitis. DARE, University of York, 2014.
Guilemany JM, Angrill J, Alobid I, Centellas S, Prades E, Roca J, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life. Allergy 2009; 64:1524–1529.
Rosenfield RM, Andes D, Bhattacharrya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137(suppl 3): 1–31.
Alobid I, Benitez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life. Comparison between the effects of medical and surgical treatments. Allergy 2005; 60: 452–8.
Marcela F, et al. The use of postopetive topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systemic review and meta-analysis. Americam Journal of Rhinology and Allergy, Sept-Oct 2013, Vol.27, No.5
Benitez P, Alobid I, de Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L, et al. A short course of oral prednisone followed by long term intranasal budesonide is an effective treatment of severe nasal polyps. Comparative study of various methods of assessment. Laryngoscope 2006; 116: 770–775.
Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic
rhinosinusitis. Otolaryngol Head Neck Surg 2009; 141: 454–461.
Wrobel BB, Leopold DA. Clinical Assessment of Patients with Smell and Taste Disorders. Otolaryngol Clin North Am 2004; 37: 1127–1142.
Guilemany JM, Alobid I, Mullol J. Controversies in the treatment of chronic rhinosinusitis. Expert Rev Respir Med 2010; 4: 463–477.
Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am 2009; 29: 657–668.
Mullol J, Alobid I. Combined oral and intranasal corticosteroid therapy: an advance in the management of nasal polyposis? Ann Intern Med 2011; 154: 365–367.
Cardesin A, Alobid I, Benitez P, Sierra E, de Haro J, Bernal-Sprekelsen M, et al. Barcelona Smell Test-24 (BAST-24): Validation and Smell Characteristics in the Healthy Spanish Population. Rhinology 2006; 44: 83–89.
Alobid I, Cardelus S, Benitez P, et al. Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology 2011; 49: 519–524.
Guilemany JM, Garcia-Pinero A, Alobid I, Cardelus S, Centellas S, Bartra J, et al. Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope 2009; 119: 233–238.
Guilemany JM, Angrill J, Alobid I, Centellas S, Pujols L, Bartra J, et al. United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. Allergy 2009; 64: 790–797.
Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of Topical Corticosteroid Powder for Nasal Polyps: a Double Blind, Placebo-Controlled Study of Budesonide. Clin Otolaryngol 1995; 20: 26–30.
Lund VJ, Mackay I. Staging in Rhinosinusitis. Rhinology 1993; 31: 183–184.
Richard F. Lockey, Dennis K. Ledford. Asthma: Comorbidities, Coexisting Conditions, and Differential Diagnosis, 2013.
